ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,544, issued on March 18, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).
"Anti-CD63 antibodies, conjugates, and uses thereof" was invented by Katherine Cygnar (New York), Andrew Baik (Bronx, N.Y.), Christopher Schoenherr (Piermont, N.Y.) and Andrew J. Murphy (Croton-on-Hudson, N.Y.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Antibodies, portions, and fusion proteins thereof to CD63 are provided. Also provided are nucleic acid sequences encoding same. Also provided are compositions comprising and methods of using same, e.g., for treating a patient in need thereof."
The patent was filed on May 17, 2019, under Application No. 17/...